BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol 2011;6:620-9. [PMID: 21148246 DOI: 10.2215/CJN.04620510] [Cited by in Crossref: 86] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 McGovern AP, de Lusignan S, van Vlymen J, Liyanage H, Tomson CR, Gallagher H, Rafiq M, Jones S. Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. PLoS One 2013;8:e74996. [PMID: 24040373 DOI: 10.1371/journal.pone.0074996] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
2 Kendrick J, Parameswaran V, Ficociello LH, Ofsthun NJ, Davis S, Mullon C, Kossmann RJ, Kalantar-Zadeh K. One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis. J Ren Nutr 2019;29:428-37. [PMID: 30679076 DOI: 10.1053/j.jrn.2018.11.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
3 Vahedi-Mazdabadi Y, Saeedi M. Treatment of Lupus Nephritis from Iranian Traditional Medicine and Modern Medicine Points of View: A Comparative Study. Evid Based Complement Alternat Med 2021;2021:6645319. [PMID: 34795786 DOI: 10.1155/2021/6645319] [Reference Citation Analysis]
4 Covic A, Rastogi A. Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence. BMC Nephrol 2013;14:153. [PMID: 23865421 DOI: 10.1186/1471-2369-14-153] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
5 Lim E, Hyun S, Lee JM, Kim S, Lee MJ, Lee SM, Oh YS, Park I, Shin GT, Kim H, Morisky DE, Jeong JC. Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial. Kidney Res Clin Pract 2018;37:69-76. [PMID: 29629279 DOI: 10.23876/j.krcp.2018.37.1.69] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
6 Rysz J, Franczyk B, Ciałkowska-Rysz A, Gluba-Brzózka A. The Effect of Diet on the Survival of Patients with Chronic Kidney Disease. Nutrients 2017;9:E495. [PMID: 28505087 DOI: 10.3390/nu9050495] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 7.2] [Reference Citation Analysis]
7 Obialo CI, Hunt WC, Bashir K, Zager PG. Relationship of missed and shortened hemodialysis treatments to hospitalization and mortality: observations from a US dialysis network. Clin Kidney J 2012;5:315-9. [PMID: 25874087 DOI: 10.1093/ckj/sfs071] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
8 Vallée M, Weinstein J, Battistella M, Papineau R, Moseley D, Wong G. Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. Int J Nephrol Renovasc Dis 2021;14:301-11. [PMID: 34393498 DOI: 10.2147/IJNRD.S318593] [Reference Citation Analysis]
9 . Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) 2013;3:112-9. [PMID: 25599001 DOI: 10.1038/kisup.2012.68] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
10 Kanda E, Bieber BA, Pisoni RL, Robinson BM, Fuller DS. Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients' mortality and development of a novel index: dialysis outcomes and practice patterns study. PLoS One 2015;10:e0128652. [PMID: 26030526 DOI: 10.1371/journal.pone.0128652] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
11 Labonté ED, Carreras CW, Leadbetter MR, Kozuka K, Kohler J, Koo-McCoy S, He L, Dy E, Black D, Zhong Z, Langsetmo I, Spencer AG, Bell N, Deshpande D, Navre M, Lewis JG, Jacobs JW, Charmot D. Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD. J Am Soc Nephrol 2015;26:1138-49. [PMID: 25404658 DOI: 10.1681/ASN.2014030317] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
12 Bhandari SK, Liu IA, Kujubu DA, Huynh T, Behayaa H, Kovesdy CP, Kalantar-Zadeh K, Jacobsen SJ, Sim JJ. Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes. Am J Nephrol 2017;45:431-41. [PMID: 28445887 DOI: 10.1159/000474959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Collinson A, McMullan M, Tse WY, Sadler H. Managing serum phosphate in haemodialysis patients: time for an innovative approach? Eur J Clin Nutr 2014;68:392-6. [PMID: 24424075 DOI: 10.1038/ejcn.2013.283] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
14 Bielopolski D, Wenziger C, Steinmetz T, Rozen Zvi B, Kalantar-Zadeh K, Streja E. Novel Protein to Phosphorous Ratio Score Predicts Mortality in Hemodialysis Patients. J Ren Nutr 2021:S1051-2276(21)00222-3. [PMID: 34740537 DOI: 10.1053/j.jrn.2021.08.008] [Reference Citation Analysis]
15 Jiang J, Li Y, Zheng D, Wang Z, Zhou H, Liu G. Fortified phosphorus‑lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease. Int J Mol Med 2020;46:1783-93. [PMID: 32901861 DOI: 10.3892/ijmm.2020.4719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Narasaki Y, Rhee CM. Dietary Therapy for Managing Hyperphosphatemia. Clin J Am Soc Nephrol 2020;16:9-11. [PMID: 33380472 DOI: 10.2215/CJN.18171120] [Reference Citation Analysis]
17 Ketteler M. Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control. Int J Nephrol 2011;2011:970245. [PMID: 21660261 DOI: 10.4061/2011/970245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY) 2019;11:4274-99. [PMID: 31241466 DOI: 10.18632/aging.102046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
19 Taketani Y, Koiwa F, Yokoyama K. Management of phosphorus load in CKD patients. Clin Exp Nephrol 2017;21:27-36. [PMID: 27896453 DOI: 10.1007/s10157-016-1360-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
20 González-Parra E, Gracia-Iguacel C, Egido J, Ortiz A. Phosphorus and nutrition in chronic kidney disease. Int J Nephrol 2012;2012:597605. [PMID: 22701173 DOI: 10.1155/2012/597605] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
21 Lopes AA, Tong L, Thumma J, Li Y, Fuller DS, Morgenstern H, Bommer J, Kerr PG, Tentori F, Akiba T, Gillespie BW, Robinson BM, Port FK, Pisoni RL. Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. Am J Kidney Dis 2012;60:90-101. [PMID: 22385781 DOI: 10.1053/j.ajkd.2011.12.025] [Cited by in Crossref: 131] [Cited by in F6Publishing: 111] [Article Influence: 13.1] [Reference Citation Analysis]
22 Yamada S, Inaba M. Potassium Metabolism and Management in Patients with CKD. Nutrients 2021;13:1751. [PMID: 34063969 DOI: 10.3390/nu13061751] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 . Chapter 3: Management of progression and complications of CKD. Kidney Int Suppl (2011) 2013;3:73-90. [PMID: 25598999 DOI: 10.1038/kisup.2012.66] [Cited by in Crossref: 64] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
24 Fukuma S, Ikenoue T, Akizawa T, Fukuhara S. Impact of nutritional index on the association between phosphorus concentrations and mortality in haemodialysis patients: a cohort study from dialysis outcomes and practice pattern study in Japan. BMJ Open 2017;7:e016682. [PMID: 28790041 DOI: 10.1136/bmjopen-2017-016682] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
25 Nixon AC, Bampouras TM, Pendleton N, Woywodt A, Mitra S, Dhaygude A. Frailty and chronic kidney disease: current evidence and continuing uncertainties. Clin Kidney J 2018;11:236-45. [PMID: 29644065 DOI: 10.1093/ckj/sfx134] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
26 Kim SM, Jung JY. Nutritional management in patients with chronic kidney disease. Korean J Intern Med 2020;35:1279-90. [PMID: 32872726 DOI: 10.3904/kjim.2020.408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Holden RM, Mustafa RA, Alexander RT, Battistella M, Bevilacqua MU, Knoll G, Mac-Way F, Reslerova M, Wald R, Acott PD, Feltmate P, Grill A, Jindal KK, Karsanji M, Kiberd BA, Mahdavi S, McCarron K, Molnar AO, Pinsk M, Rodd C, Soroka SD, Vinson AJ, Zimmerman D, Clase CM. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder. Can J Kidney Health Dis 2020;7:2054358120944271. [PMID: 32821415 DOI: 10.1177/2054358120944271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Huang N, Li H, Fan L, Zhou Q, Fu D, Guo L, Yi C, Yu X, Mao H. Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality. Front Med (Lausanne) 2021;8:760394. [PMID: 34926505 DOI: 10.3389/fmed.2021.760394] [Reference Citation Analysis]
29 Gong N, Xiao Z, Zhang F, Zhong X, He Y, Yi Z, Tang D, Yang C, Lin Y, Nie J, Ai J. Duration of Serum Phosphorus Control Associated with Overall Mortality in Patients Undergoing Peritoneal Dialysis. Kidney Dis (Basel) 2020;6:434-43. [PMID: 33313064 DOI: 10.1159/000507785] [Reference Citation Analysis]
30 Ilori TO, Sun Ro Y, Kong SY, Gutierrez OM, Ojo AO, Judd SE, Narayan KM, Goodman M, Plantinga L, McClellan W. Oxidative Balance Score and Chronic Kidney Disease. Am J Nephrol 2015;42:320-7. [PMID: 26569393 DOI: 10.1159/000441623] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
31 Tani T, Fujiwara M, Orimo H, Shimizu A, Narisawa S, Pinkerton AB, Millán JL, Tsuruoka S. Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model. J Pathol 2020;250:30-41. [PMID: 31509234 DOI: 10.1002/path.5346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
32 Naber T, Purohit S. Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease. Nutrients 2021;13:3277. [PMID: 34579153 DOI: 10.3390/nu13093277] [Reference Citation Analysis]
33 Zitt E, Lamina C, Sturm G, Knoll F, Lins F, Freistätter O, Kronenberg F, Lhotta K, Neyer U. Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients. Clin J Am Soc Nephrol 2011;6:2650-6. [PMID: 21903986 DOI: 10.2215/CJN.03780411] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
34 Umeukeje EM, Merighi JR, Browne T, Victoroff JN, Umanath K, Lewis JB, Ikizler TA, Wallston KA, Cavanaugh K. Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease. J Ren Nutr 2015;25:433-9. [PMID: 25912398 DOI: 10.1053/j.jrn.2015.03.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
35 Kalantar-Zadeh K, Ficociello LH, Parameswaran V, Athienites NV, Mullon C, Kossmann RJ, Coyne DW. Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study. BMC Nephrol 2019;20:396. [PMID: 31664928 DOI: 10.1186/s12882-019-1582-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Snelson M, Clarke RE, Coughlan MT. Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD? Nutrients 2017;9:E265. [PMID: 28287463 DOI: 10.3390/nu9030265] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
37 Kalantar-Zadeh K, Tortorici AR, Chen JL, Kamgar M, Lau WL, Moradi H, Rhee CM, Streja E, Kovesdy CP. Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial 2015;28:159-68. [PMID: 25649719 DOI: 10.1111/sdi.12348] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 14.3] [Reference Citation Analysis]
38 Sinha A, Prasad N. Dietary management of hyperphosphatemia in chronic kidney disease. Clinical Queries: Nephrology 2014;3:38-45. [DOI: 10.1016/j.cqn.2014.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
39 Navarro-González JF, Arenas MD, Henríquez-Palop F, Lloret MJ, Molina P, Ríos Moreno F, Macia-Lagier MA, Espinel L, Sánchez E, Lago M, Crespo A, Bover J. Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: the VELREAL multicentre study. Clin Kidney J 2021;14:681-7. [PMID: 33626111 DOI: 10.1093/ckj/sfaa226] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Mc Causland FR, Waikar SS, Brunelli SM. Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int 2012;82:204-11. [PMID: 22418981 DOI: 10.1038/ki.2012.42] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
41 Ebrahim Z, Esau N, Cilliers L. Keeping the Diet Simple and Natural in Chronic Kidney Disease: A South African-Based Dietary Infographic. J Ren Nutr 2020;30:e58-65. [PMID: 32303412 DOI: 10.1053/j.jrn.2019.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Shimada M, Shutto-Uchita Y, Yamabe H. Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern. In Vivo 2019;33:11-6. [PMID: 30587596 DOI: 10.21873/invivo.11432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
43 Lloret MJ, Ruiz-García C, Dasilva I, Furlano M, Barreiro Y, Ballarín J, Bover J. Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence. Patient Prefer Adherence 2013;7:1147-56. [PMID: 24235818 DOI: 10.2147/PPA.S31694] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
44 Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Prefer Adherence 2018;12:1175-91. [PMID: 30013329 DOI: 10.2147/PPA.S145648] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
45 Garagarza C, Valente A, Caetano C, Oliveira T, Ponce P, Silva AP. Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients. Int Urol Nephrol 2017;49:1243-50. [PMID: 28265965 DOI: 10.1007/s11255-017-1558-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
46 Clegg DJ, Hill Gallant KM. Plant-Based Diets in CKD. Clin J Am Soc Nephrol 2019;14:141-3. [PMID: 30587492 DOI: 10.2215/CJN.08960718] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
47 Ketteler M, Wüthrich RP, Floege J. Management of hyperphosphataemia in chronic kidney disease-challenges and solutions. Clin Kidney J 2013;6:128-36. [PMID: 26019840 DOI: 10.1093/ckj/sfs173] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
48 Gutiérrez OM, Muntner P, Rizk DV, McClellan WM, Warnock DG, Newby PK, Judd SE. Dietary patterns and risk of death and progression to ESRD in individuals with CKD: a cohort study. Am J Kidney Dis 2014;64:204-13. [PMID: 24679894 DOI: 10.1053/j.ajkd.2014.02.013] [Cited by in Crossref: 93] [Cited by in F6Publishing: 81] [Article Influence: 11.6] [Reference Citation Analysis]
49 Piccoli GB, Moio MR, Fois A, Sofronie A, Gendrot L, Cabiddu G, D'Alessandro C, Cupisti A. The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach. Nutrients 2017;9:E372. [PMID: 28394304 DOI: 10.3390/nu9040372] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
50 Komaba H, Wang M, Taniguchi M, Yamamoto S, Nomura T, Schaubel DE, Smith AR, Zee J, Karaboyas A, Bieber B, Fukagawa M, Tentori F. Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders. Clin J Am Soc Nephrol 2017;12:1489-97. [PMID: 28724618 DOI: 10.2215/CJN.13091216] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
51 Kalantar-Zadeh K, Parameswaran V, Ficociello LH, Anderson L, Ofsthun NJ, Kwoh C, Mullon C, Kossmann RJ, Coyne DW. Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide. Am J Nephrol 2018;47:153-61. [PMID: 29514139 DOI: 10.1159/000487856] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
52 Sridhar NR, Josyula S. Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study. BMC Nephrol 2013;14:242. [PMID: 24499139 DOI: 10.1186/1471-2369-14-242] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
53 Hwang E, Choi BS, Oh KH, Kwon YJ, Kim GH. Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations. Kidney Res Clin Pract 2015;34:4-12. [PMID: 26484013 DOI: 10.1016/j.krcp.2015.02.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
54 Ben-Porat T, Weiss-Sadan A, Rottenstreich A, Sherf-Dagan S, Schweiger C, Yosef-Levi IM, Weiner D, Azulay O, Sakran N, Harari R, Elazary R. Nutritional Management for Chronic Kidney Disease Patients who Undergo Bariatric Surgery: A Narrative Review. Adv Nutr 2019;10:122-32. [PMID: 30753268 DOI: 10.1093/advances/nmy112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]